Cutting Edge Diagnostics

Sequenom, a leader in genetic analysis products, is developing cutting edge diagnostic products to improve healthcare.

The company develops and markets its line of SensiGene™ branded laboratory tests through its wholly-owned subsidiary - Sequenom Center for Molecular Medicine® (Sequenom CMM), a CAP accredited and CLIA-certified molecular diagnostics laboratory. The laboratory is developing a full range of advanced diagnostics. Branded under the name SensiGene, these genetic tests provide earlier patient management alternatives for obstetricians, geneticists and maternal fetal medicine specialists. Sequenom CMM is changing the landscape in genetic disorder diagnostics using proprietary cutting edge technologies.

Visit http://www.scmmlab.com for more information on the company's laboratory services.